Network identification

Network ID

1000000449

Network name and Acronym

TIMESPAN

Network website

Network countries

Australia
Denmark
Germany
Hong Kong
Iceland
Ireland
Italy
Netherlands
Norway
Spain
Sweden
United Kingdom
United States

ENCePP partner

No
Network description
The EU-funded TIMESPAN project aims to advance the management of patients with attention deficit hyperactivity disorder (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification.
The two conditions share substantial comorbidity and common genetics, with cardiometabolic disease leading to premature deaths and placing a substantial burden on healthcare systems.
Moreover, the co-existence of psychiatric disorders in patients with this profile cannot be overlooked.
The project's work is expected to improve the clinical outcomes as well as the quality of life of adult ADHD patients with co-occurring cardiometabolic disease.
Network details
Network primary therapeutic area:
Cardiovascular diseases
Other
Psychiatry
Network funding:
EU institutional research programme

Contact

Institutions that are part of this network

University of Groningen
UCL School of Pharmacy, University College London
Psychiatric Epidemiology (Psychepi Sweden), Örebro University
Clinical Pharmacology, Vall d'Hebron Institut de Recerca (VHIR)
University of Tartu
University of New South Wales (UNSW Sydney)
Karolinska Institutet
Aarhus University
King's College London
Universitetet i Bergen (UiB); SUNY Upstate Medical University; EMPATICA SRL (EMPATICA); University of Iceland; The University of Hong Kong (HKU); ADDISS; The European Association for the Study of Obesity; Concentris research management GMBH

Studies conducted by the network